Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extension.
J Clin Endocrinol Metab. 2013 Mar;98(3):1154-62. doi: 10.1210/jc.2012-3249. Epub 2013 Feb 7.
J Clin Endocrinol Metab. 2013.
PMID: 23393185
Free PMC article.
Clinical Trial.
Adding fast-acting insulin aspart to basal insulin significantly improved glycaemic control in patients with type 2 diabetes: A randomized, 18-week, open-label, phase 3 trial (onset 3).
Rodbard HW, Tripathy D, Vidrio Velázquez M, Demissie M, Tamer SC, Piletič M.
Rodbard HW, et al. Among authors: tamer sc.
Diabetes Obes Metab. 2017 Oct;19(10):1389-1396. doi: 10.1111/dom.12955. Epub 2017 Jul 6.
Diabetes Obes Metab. 2017.
PMID: 28345792
Free PMC article.
Clinical Trial.
Item in Clipboard
Insulin degludec compared with insulin glargine in insulin-naïve patients with type 2 diabetes: A 26-week, randomized, controlled, Pan-Asian, treat-to-target trial.
Onishi Y, Iwamoto Y, Yoo SJ, Clauson P, Tamer SC, Park S.
Onishi Y, et al. Among authors: tamer sc.
J Diabetes Investig. 2013 Nov 27;4(6):605-12. doi: 10.1111/jdi.12102. Epub 2013 Jun 3.
J Diabetes Investig. 2013.
PMID: 24843715
Free PMC article.
Item in Clipboard
Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
Bode BW, Johnson JA, Hyveled L, Tamer SC, Demissie M.
Bode BW, et al. Among authors: tamer sc.
Diabetes Technol Ther. 2017 Jan;19(1):25-33. doi: 10.1089/dia.2016.0350. Epub 2017 Jan 5.
Diabetes Technol Ther. 2017.
PMID: 28055230
Free PMC article.
Clinical Trial.
Item in Clipboard
Insulin detemir results in less weight gain than NPH insulin when used in basal-bolus therapy for type 2 diabetes mellitus, and this advantage increases with baseline body mass index.
Raslová K, Tamer SC, Clauson P, Karl D.
Raslová K, et al. Among authors: tamer sc.
Clin Drug Investig. 2007;27(4):279-85. doi: 10.2165/00044011-200727040-00007.
Clin Drug Investig. 2007.
PMID: 17358100
Clinical Trial.
Item in Clipboard
Ofatumumab, a human anti-CD20 monoclonal antibody, for treatment of rheumatoid arthritis with an inadequate response to one or more disease-modifying antirheumatic drugs: results of a randomized, double-blind, placebo-controlled, phase I/II study.
Østergaard M, Baslund B, Rigby W, Rojkovich B, Jorgensen C, Dawes PT, Wiell C, Wallace DJ, Tamer SC, Kastberg H, Petersen J, Sierakowski S.
Østergaard M, et al. Among authors: tamer sc.
Arthritis Rheum. 2010 Aug;62(8):2227-38. doi: 10.1002/art.27524.
Arthritis Rheum. 2010.
PMID: 20506254
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite